申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:EP0718286A1
公开(公告)日:1996-06-26
Novel 3-alkoxybenzylpiperidines of formula (I) have melatonergic properties. They are believed useful in treating depression, jet-lag, work-shift syndrome, sleep disorders, glaucoma, some disorders associated with reproduction, cancer, immune disorders and neuroendocrine disorders.
式(I)的新型 3-烷氧基苄基哌啶具有褪黑激素能。据信,它们可用于治疗抑郁症、时差、倒班综合征、睡眠障碍、青光眼、某些与生殖有关的疾病、癌症、免疫紊乱和神经内分泌失调。